Annual SGA
$24.56 M
+$9.24 M+60.32%
June 30, 2024
Summary
- As of March 2, 2025, RENB annual SGA is $24.56 million, with the most recent change of +$9.24 million (+60.32%) on June 30, 2024.
- During the last 3 years, RENB annual SGA has risen by +$17.00 million (+224.92%).
- RENB annual SGA is now at all-time high.
Performance
RENB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.35 M
-$948.20 K-17.89%
December 31, 2024
Summary
- As of March 2, 2025, RENB quarterly SGA is $4.35 million, with the most recent change of -$948.20 thousand (-17.89%) on December 31, 2024.
- Over the past year, RENB quarterly SGA has dropped by -$645.50 thousand (-12.91%).
- RENB quarterly SGA is now -47.49% below its all-time high of $8.29 million, reached on September 30, 2023.
Performance
RENB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.36 B
-$126.19 M-10.23%
December 31, 2024
Summary
- As of March 2, 2025, RENB TTM SGA is -$1.36 billion, with the most recent change of -$126.19 million (-10.23%) on December 31, 2024.
- Over the past year, RENB TTM SGA has dropped by -$1.38 billion (-5638.10%).
- RENB TTM SGA is now -3964984.26% below its all-time high of -$34.30 thousand.
Performance
RENB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RENB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.3% | -12.9% | -5638.1% |
| 3 y3 years | +224.9% | -12.9% | -5638.1% |
| 5 y5 years | +191.7% | -12.9% | -5638.1% |
RENB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +224.9% | -47.5% | +56.0% | -263.9% | at low |
| 5 y | 5-year | at high | +244.9% | -47.5% | +192.8% | -495.7% | at low |
| alltime | all time | at high | >+9999.0% | -47.5% | -100.0% | <-9999.0% | at low |
Renovaro Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $4.35 M(-17.9%) | $22.31 M(+3.4%) |
| Sep 2024 | - | $5.30 M(+6.1%) | $21.57 M(-12.2%) |
| Jun 2024 | $24.56 M(+60.3%) | $5.00 M(-34.7%) | $24.56 M(+9.1%) |
| Mar 2024 | - | $7.65 M(+111.6%) | $22.51 M(+20.7%) |
| Dec 2023 | - | $3.62 M(-56.4%) | $18.65 M(-2.1%) |
| Sep 2023 | - | $8.29 M(+180.8%) | $19.05 M(+24.4%) |
| Jun 2023 | $15.32 M(+6.9%) | - | - |
| Jun 2023 | - | $2.95 M(-22.2%) | $15.32 M(-1.3%) |
| Mar 2023 | - | $3.80 M(-5.4%) | $15.53 M(+6.9%) |
| Dec 2022 | - | $4.01 M(-11.9%) | $14.52 M(+0.4%) |
| Sep 2022 | - | $4.56 M(+44.2%) | $14.47 M(+1.0%) |
| Jun 2022 | $14.33 M(+89.6%) | $3.16 M(+13.2%) | $14.33 M(+8.8%) |
| Mar 2022 | - | $2.79 M(-29.6%) | $13.18 M(+7.2%) |
| Dec 2021 | - | $3.96 M(-10.3%) | $12.29 M(+19.7%) |
| Sep 2021 | - | $4.42 M(+120.1%) | $10.27 M(+34.6%) |
| Jun 2021 | $7.56 M(+6.1%) | $2.01 M(+5.4%) | $7.63 M(+7.1%) |
| Mar 2021 | - | $1.90 M(-1.9%) | $7.12 M(+6.2%) |
| Dec 2020 | - | $1.94 M(+9.1%) | $6.70 M(-4.2%) |
| Sep 2020 | - | $1.78 M(+18.7%) | $7.00 M(-1.7%) |
| Jun 2020 | $7.12 M(-15.4%) | $1.50 M(+0.8%) | $7.12 M(-1.1%) |
| Mar 2020 | - | $1.49 M(-33.5%) | $7.20 M(-6.1%) |
| Dec 2019 | - | $2.24 M(+17.6%) | $7.66 M(-14.9%) |
| Sep 2019 | - | $1.90 M(+20.7%) | $9.01 M(+7.0%) |
| Jun 2019 | $8.42 M(+79.4%) | $1.57 M(-19.3%) | $8.42 M(+9.7%) |
| Mar 2019 | - | $1.95 M(-45.5%) | $7.67 M(-4.8%) |
| Dec 2018 | - | $3.58 M(+172.5%) | $8.06 M(+45.5%) |
| Sep 2018 | - | $1.31 M(+58.6%) | $5.54 M(+18.0%) |
| Jun 2018 | $4.69 M | $828.60 K(-64.6%) | $4.69 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $2.34 M(+121.3%) | $4.49 M(+80.8%) |
| Dec 2017 | - | $1.06 M(+125.8%) | $2.49 M(+26.8%) |
| Sep 2017 | - | $468.20 K(-25.6%) | $1.96 M(-15.6%) |
| Jun 2017 | $2.32 M(+75.1%) | $629.10 K(+89.9%) | $2.32 M(+6.9%) |
| Mar 2017 | - | $331.20 K(-37.7%) | $2.17 M(+2.7%) |
| Dec 2016 | - | $531.40 K(-36.1%) | $2.12 M(+10.0%) |
| Sep 2016 | - | $831.40 K(+73.8%) | $1.92 M(+44.9%) |
| Jun 2016 | $1.33 M(+28.2%) | $478.50 K(+74.6%) | $1.33 M(+56.4%) |
| Mar 2016 | - | $274.00 K(-19.1%) | $848.30 K(-31.6%) |
| Dec 2015 | - | $338.60 K(+43.7%) | $1.24 M(-29.6%) |
| Sep 2015 | - | $235.70 K(-64.6%) | $1.76 M(-26.4%) |
| Jun 2015 | $1.04 M(-51.0%) | - | - |
| Mar 2015 | - | $665.00 K(-22.7%) | $2.39 M(+13.1%) |
| Dec 2014 | $2.11 M(+5599.7%) | $860.60 K(+135.5%) | $2.11 M(+67.5%) |
| Sep 2014 | - | $365.50 K(-27.0%) | $1.26 M(+38.3%) |
| Jun 2014 | - | $500.90 K(+29.2%) | $912.60 K(+120.3%) |
| Mar 2014 | - | $387.60 K(+4685.2%) | $414.20 K(+1050.6%) |
| Dec 2013 | - | $8100.00(-49.4%) | $36.00 K(-4.0%) |
| Sep 2013 | - | $16.00 K(+540.0%) | $37.50 K(+31.6%) |
| Jun 2013 | - | $2500.00(-73.4%) | $28.50 K(-23.0%) |
| Mar 2013 | $37.10 K(+24.1%) | $9400.00(-2.1%) | $37.00 K(+15.6%) |
| Dec 2012 | - | $9600.00(+37.1%) | $32.00 K(-5.3%) |
| Sep 2012 | - | $7000.00(-36.4%) | $33.80 K(-17.6%) |
| Jun 2012 | - | $11.00 K(+150.0%) | $41.00 K(+36.7%) |
| Mar 2012 | $29.90 K(-12.8%) | $4400.00(-61.4%) | $30.00 K(+17.2%) |
| Dec 2011 | $34.30 K | $11.40 K(-19.7%) | $25.60 K(+80.3%) |
| Sep 2011 | - | $14.20 K(>+9900.0%) | $14.20 K(>+9900.0%) |
| Jun 2011 | - | $0.00 | $0.00 |
FAQ
- What is Renovaro Biosciences annual SGA?
- What is the all time high annual SGA for Renovaro Biosciences?
- What is Renovaro Biosciences annual SGA year-on-year change?
- What is Renovaro Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly SGA year-on-year change?
- What is Renovaro Biosciences TTM SGA?
- What is the all time high TTM SGA for Renovaro Biosciences?
- What is Renovaro Biosciences TTM SGA year-on-year change?
What is Renovaro Biosciences annual SGA?
The current annual SGA of RENB is $24.56 M
What is the all time high annual SGA for Renovaro Biosciences?
Renovaro Biosciences all-time high annual SGA is $24.56 M
What is Renovaro Biosciences annual SGA year-on-year change?
Over the past year, RENB annual SGA has changed by +$9.24 M (+60.32%)
What is Renovaro Biosciences quarterly SGA?
The current quarterly SGA of RENB is $4.35 M
What is the all time high quarterly SGA for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly SGA is $8.29 M
What is Renovaro Biosciences quarterly SGA year-on-year change?
Over the past year, RENB quarterly SGA has changed by -$645.50 K (-12.91%)
What is Renovaro Biosciences TTM SGA?
The current TTM SGA of RENB is -$1.36 B
What is the all time high TTM SGA for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM SGA is -$34.30 K
What is Renovaro Biosciences TTM SGA year-on-year change?
Over the past year, RENB TTM SGA has changed by -$1.38 B (-5638.10%)